Longboard Pharmaceuticals | 4:持股变动声明-高管 Kaye Randall
Longboard Pharmaceuticals | 4:持股变动声明-高管 Lind Kevin Robert
Longboard Pharmaceuticals | 4:持股变动声明-高管 Kaye Randall
Longboard Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Viking Global Investors LP(5.2%),Viking Global Opportunities Parent GP LLC(5.2%)等
Longboard Pharmaceuticals | 4:持股变动声明-董事 SEKHRI PAUL J
Longboard Pharmaceuticals | 4:持股变动声明-董事 SCHNEIDER PHILLIP M
Longboard Pharmaceuticals | 4:持股变动声明-董事 Lynch Casey
Longboard Pharmaceuticals | 4:持股变动声明-董事 Le Goff Corinne
Longboard Pharmaceuticals | 4:持股变动声明-董事 Aurentz Vincent
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.749%),Abigail P. Johnson(12.749%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(9.99%),Bihua Chen(9.99%)等
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(7.6%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.8%),Point72 Capital Advisors, Inc.(3.8%)等
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-HBM Healthcare Investments (Cayman) Ltd.(0%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Prosight Management, LP(0.0%),Prosight Fund, LP(0.0%)等
Longboard Pharmaceuticals | 4:持股变动声明-高管 Kaye Randall
Longboard Pharmaceuticals | 4:持股变动声明-高管 Roberts Brandi
Longboard Pharmaceuticals | 4:持股变动声明-高管 Lind Kevin Robert
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(7.694%),Abigail P. Johnson(7.694%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Joshua J. Dapice(9.99%),Philip D. Dreyfuss(9.99%)等
暂无数据
暂无数据